Immatics at the CPRIT Conference 2017 (Nov 13 – Nov 14) in Austin, USA

We look forward to seeing you at the CPRIT Conference 2017

Immatics will present

 

Monday, Nov 13

10am - 11.30am

Immunotherapy Panel: "Evolving Developments in Immunotherapy: A Look at the Future"

Speaker: Harpreet Singh (CEO)

Location: Ballroom A

 

Monday, Nov 13

2.20pm - 2.35pm

Product Showcase Session: Immatics Company Presentation

Presenter: Harpreet Singh (CEO)

Location: Auditorium

 

Tuesday, Nov 14

10.30am - 11.30am

Poster: Phase I trial evaluating genetically modified autologous T cells expressing a T-cell receptor recognizing a cancer/germline antigen in patients with squamous NSCLC or HNSCC (ACTengine® IMA201-101) (Poster Session B; ID 319)

Poster: Phase I adoptive cellular therapy trial with autologous, multi-target CD8+ T-cells in patients with relapsed and/or refractory solid cancers (ACTolog®) (Poster Session B; ID 320)

Presenter: Steffen Walter (CSO)

Location: Rio Grande Exhibit Hall

 

Tuesday, Nov 14

2.25pm - 4pm

Panel Discussion: Start Up Trials and Tribulations

Speaker: Harpreet Singh (CEO)

Location: Glass Oaks Room

 

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back